Previous close | 329.20 |
Open | 0.00 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 329.20 - 329.20 |
52-week range | 259.22 - 526.22 |
Volume | |
Avg. volume | 3,174 |
Market cap | 314.568B |
Beta (5Y monthly) | 0.69 |
PE ratio (TTM) | 4.40 |
EPS (TTM) | 74.75 |
Earnings date | 29 Jul 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Philips MR 5300 BlueSeal installation at Vida Imaging & Breast Center, Bayamon, Puerto Rico Exterior picture of Vida Imaging & Breast Center, Bayamon, Puerto Rico A clinician using a Philips MR 5300 May 30, 2024 First to provide helium-free operations in 2018, Philips marks milestone during installation in Puerto Rico Amsterdam, the Netherlands and Bayamón, Puerto Rico – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and world leader in proven helium-free [1] MRI ope
May 23, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the successful pricing of its offering of EUR 700 million fixed rate notes due 2032 (the “Notes”) under its European Medium Term Note (EMTN) program. The issue of the Notes will have a debt-neutral effect, as the net proceeds of the transaction will be used for repayment of debt in 2024 and 2025. The issue price for the Notes is 98.257% with a Coupon of 3.75%, res
Woman wearing Philips ePatch Philips ePatch Dr. Jorge Pagola Val dHebron Philips Cardiologs AI analytics platform May 22, 2024 Philips wearable ePatch and AI analytics platform help detect potentially life-threatening irregular heartbeatsThe solution helps University Hospital Vall d’Hebron achieve reduced average length of stay, relieve emergency room pressure, and reduce costs Amsterdam, the Netherlands, and Madrid, Spain – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technol